{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,12]],"date-time":"2026-04-12T20:09:15Z","timestamp":1776024555649,"version":"3.50.1"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100012021","name":"Iran University of Medical Sciences","doi-asserted-by":"crossref","award":["95-04-30- 29364"],"award-info":[{"award-number":["95-04-30- 29364"]}],"id":[{"id":"10.13039\/100012021","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>This study is aimed to unravel the status of local and circulating \u03b2-catenin in different primary bone tumors and its relevance to tumor types, severity, and chemotherapy. The \u03b2-catenin mRNA expression level and the expression of the protein (intensity level) were evaluated in tumor tissue and peripheral blood mononuclear cells of 150 patients with different types of primary bone tumors (78 malignant and 72 benign tumors) using Real-Time PCR and immunohistochemistry. The \u03b2-catenin mRNA expression level and the expression of the protein were increased in bone tumors which was positively correlated with the tumor malignancy. Amongst osteosarcoma, Ewing's Sarcoma, chondrosarcoma, osteochondroma, Giant Cell Tumor, and exostosis tumors, the osteosarcoma, and Giant Cell Tumor groups showed the highest level of \u03b2-catenin expression. The \u03b2-catenin expression in malignant bone tumors was significantly correlated with tumor grade, size, metastasis, tumor recurrent, and the level of response to chemotherapy. A similar pattern of \u03b2-catenin gene expression and its association with tumor characteristics was detected in the patient's peripheral blood cells. The simultaneous increase in the expression of the \u03b2-catenin gene and protein in tumor tissue and in circulating blood cells and its relationship with tumor severity indicates the possible promoting role of \u03b2-catenin in primary bone tumor pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-022-13685-1","type":"journal-article","created":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T17:04:00Z","timestamp":1654707840000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Expression pattern and clinical significance of \u03b2-catenin gene and protein in patients with primary malignant and benign bone tumors"],"prefix":"10.1038","volume":"12","author":[{"given":"Narges","family":"Khademian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Mirzaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ameinh","family":"Hosseini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leila","family":"Zare","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shima","family":"Nazem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pegah","family":"Babaheidarian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alireza","family":"Sheikhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohreh","family":"Abdolvahabi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mostafa","family":"Ibrahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khodamorad","family":"Jamshidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahtab","family":"Rahbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vahid","family":"Salimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4449-9248","authenticated-orcid":false,"given":"Masoumeh","family":"Tavakoli-Yaraki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,6,8]]},"reference":[{"key":"13685_CR1","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00223-017-0372-2","volume":"102","author":"HK Brown","year":"2018","unstructured":"Brown, H. K., Schiavone, K., Gouin, F., Heymann, M. F. & Heymann, D. Biology of bone sarcomas and new therapeutic developments. Calcif. Tissue Int. 102, 174\u2013195. https:\/\/doi.org\/10.1007\/s00223-017-0372-2 (2018).","journal-title":"Calcif. Tissue Int."},{"key":"13685_CR2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20010170","author":"S Miwa","year":"2019","unstructured":"Miwa, S. et al. Therapeutic targets for bone and soft-tissue sarcomas. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20010170 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"13685_CR3","first-page":"205","volume":"98","author":"JL Ferguson","year":"2018","unstructured":"Ferguson, J. L. & Turner, S. P. Bone cancer: Diagnosis and treatment principles. Am. Fam. Physician 98, 205\u2013213 (2018).","journal-title":"Am. Fam. Physician"},{"key":"13685_CR4","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1007\/s00223-017-0362-4","volume":"102","author":"RW Johnson","year":"2018","unstructured":"Johnson, R. W. & Suva, L. J. Hallmarks of bone metastasis. Calcif. Tissue Int. 102, 141\u2013151. https:\/\/doi.org\/10.1007\/s00223-017-0362-4 (2018).","journal-title":"Calcif. Tissue Int."},{"key":"13685_CR5","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/nrc3419","volume":"13","author":"JN Anastas","year":"2013","unstructured":"Anastas, J. N. & Moon, R. T. WNT signalling pathways as therapeutic targets in cancer. Nat. Rev. Cancer 13, 11\u201326. https:\/\/doi.org\/10.1038\/nrc3419 (2013).","journal-title":"Nat. Rev. Cancer"},{"key":"13685_CR6","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","volume":"12","author":"N Takebe","year":"2015","unstructured":"Takebe, N. et al. Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: Clinical update. Nat. Rev. Clin. Oncol. 12, 445\u2013464. https:\/\/doi.org\/10.1038\/nrclinonc.2015.61 (2015).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"13685_CR7","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.tibs.2018.06.003","volume":"43","author":"C Cui","year":"2018","unstructured":"Cui, C., Zhou, X., Zhang, W., Qu, Y. & Ke, X. Is beta-catenin a druggable target for cancer therapy?. Trends Biochem. Sci. 43, 623\u2013634. https:\/\/doi.org\/10.1016\/j.tibs.2018.06.003 (2018).","journal-title":"Trends Biochem. Sci."},{"key":"13685_CR8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nm.3074","volume":"19","author":"R Baron","year":"2013","unstructured":"Baron, R. & Kneissel, M. WNT signaling in bone homeostasis and disease: From human mutations to treatments. Nat. Med. 19, 179\u2013192. https:\/\/doi.org\/10.1038\/nm.3074 (2013).","journal-title":"Nat. Med."},{"key":"13685_CR9","doi-asserted-by":"publisher","first-page":"E478","DOI":"10.1073\/pnas.1409857112","volume":"112","author":"X Tu","year":"2015","unstructured":"Tu, X. et al. Osteocytes mediate the anabolic actions of canonical Wnt\/beta-catenin signaling in bone. Proc. Natl. Acad. Sci. USA 112, E478-486. https:\/\/doi.org\/10.1073\/pnas.1409857112 (2015).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"13685_CR10","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biocel.2016.05.015","volume":"77","author":"P Duan","year":"2016","unstructured":"Duan, P. & Bonewald, L. F. The role of the wnt\/beta-catenin signaling pathway in formation and maintenance of bone and teeth. Int. J. Biochem. Cell Biol. 77, 23\u201329. https:\/\/doi.org\/10.1016\/j.biocel.2016.05.015 (2016).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"13685_CR11","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3760\/cma.j.issn.0529-5815.2018.10.020","volume":"56","author":"ZH Zhou","year":"2018","unstructured":"Zhou, Z. H. & Xiao, J. R. Regulation of Wnt\/beta-catenin signaling in bone development and bone tumor. Zhonghua wai ke za zhi [Chin. J. Surg.] 56, 797\u2013800. https:\/\/doi.org\/10.3760\/cma.j.issn.0529-5815.2018.10.020 (2018).","journal-title":"Zhonghua wai ke za zhi [Chin. J. Surg.]"},{"key":"13685_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1007\/s11914-017-0377-9","volume":"15","author":"MG Pridgeon","year":"2017","unstructured":"Pridgeon, M. G., Grohar, P. J., Steensma, M. R. & Williams, B. O. Wnt signaling in ewing sarcoma, osteosarcoma, and malignant peripheral nerve sheath tumors. Curr. Osteoporos. Rep. 15, 239\u2013246. https:\/\/doi.org\/10.1007\/s11914-017-0377-9 (2017).","journal-title":"Curr. Osteoporos. Rep."},{"key":"13685_CR13","doi-asserted-by":"publisher","first-page":"2368","DOI":"10.1128\/mcb.01780-07","volume":"28","author":"Y Endo","year":"2008","unstructured":"Endo, Y. et al. Wnt-3a and Dickkopf-1 stimulate neurite outgrowth in Ewing tumor cells via a Frizzled3- and c-Jun N-terminal kinase-dependent mechanism. Mol. Cell. Biol. 28, 2368\u20132379. https:\/\/doi.org\/10.1128\/mcb.01780-07 (2008).","journal-title":"Mol. Cell. Biol."},{"key":"13685_CR14","doi-asserted-by":"publisher","first-page":"5069","DOI":"10.1038\/onc.2014.429","volume":"34","author":"S Zhao","year":"2015","unstructured":"Zhao, S. et al. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene 34, 5069\u20135079. https:\/\/doi.org\/10.1038\/onc.2014.429 (2015).","journal-title":"Oncogene"},{"key":"13685_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/1476-4598-6-62","volume":"6","author":"K Ishida","year":"2007","unstructured":"Ishida, K. et al. Nuclear localization of beta-catenin involved in precancerous change in oral leukoplakia. Mol. Cancer 6, 62. https:\/\/doi.org\/10.1186\/1476-4598-6-62 (2007).","journal-title":"Mol. Cancer"},{"key":"13685_CR16","doi-asserted-by":"publisher","first-page":"612","DOI":"10.1111\/j.1365-2559.2006.02560.x","volume":"49","author":"N Ogasawara","year":"2006","unstructured":"Ogasawara, N. et al. Mutations and nuclear accumulation of beta-catenin correlate with intestinal phenotypic expression in human gastric cancer. Histopathology 49, 612\u2013621. https:\/\/doi.org\/10.1111\/j.1365-2559.2006.02560.x (2006).","journal-title":"Histopathology"},{"key":"13685_CR17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0111885","volume":"9","author":"J Chen","year":"2014","unstructured":"Chen, J. et al. Cytoplasmic and\/or nuclear expression of \u03b2-catenin correlate with poor prognosis and unfavorable clinicopathological factors in hepatocellular carcinoma: A meta-analysis. PLoS ONE 9, e111885. https:\/\/doi.org\/10.1371\/journal.pone.0111885 (2014).","journal-title":"PLoS ONE"},{"key":"13685_CR18","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1093\/embo-reports\/kvf002","volume":"3","author":"FJ Staal","year":"2002","unstructured":"Staal, F. J., van Noort, M., Strous, G. J. & Clevers, H. C. Wnt signals are transmitted through N-terminally dephosphorylated beta-catenin. EMBO Rep. 3, 63\u201368. https:\/\/doi.org\/10.1093\/embo-reports\/kvf002 (2002).","journal-title":"EMBO Rep."},{"key":"13685_CR19","doi-asserted-by":"publisher","first-page":"368","DOI":"10.18632\/genesandcancer.128","volume":"7","author":"A Persad","year":"2016","unstructured":"Persad, A. et al. Active \u03b2-catenin is regulated by the PTEN\/PI3 kinase pathway: A role for protein phosphatase PP2A. Genes Cancer 7, 368\u2013382. https:\/\/doi.org\/10.18632\/genesandcancer.128 (2016).","journal-title":"Genes Cancer"},{"key":"13685_CR20","doi-asserted-by":"publisher","first-page":"2123","DOI":"10.3892\/ol.2015.3535","volume":"10","author":"Y Lu","year":"2015","unstructured":"Lu, Y. et al. Aberrant CXCR4 and beta-catenin expression in osteosarcoma correlates with patient survival. Oncol. Lett. 10, 2123\u20132129. https:\/\/doi.org\/10.3892\/ol.2015.3535 (2015).","journal-title":"Oncol. Lett."},{"key":"13685_CR21","doi-asserted-by":"publisher","first-page":"43124","DOI":"10.18632\/oncotarget.8988","volume":"7","author":"P De","year":"2016","unstructured":"De, P. et al. Wnt-beta-catenin pathway signals metastasis-associated tumor cell phenotypes in triple negative breast cancers. Oncotarget 7, 43124\u201343149. https:\/\/doi.org\/10.18632\/oncotarget.8988 (2016).","journal-title":"Oncotarget"},{"key":"13685_CR22","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3892\/ijo.2016.3360","volume":"48","author":"X Wu","year":"2016","unstructured":"Wu, X., Luo, F., Li, J., Zhong, X. & Liu, K. Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway. Int. J. Oncol. 48, 1333\u20131340. https:\/\/doi.org\/10.3892\/ijo.2016.3360 (2016).","journal-title":"Int. J. Oncol."},{"key":"13685_CR23","doi-asserted-by":"publisher","first-page":"3153","DOI":"10.1158\/1078-0432.Ccr-09-2943","volume":"16","author":"F Takahashi-Yanaga","year":"2010","unstructured":"Takahashi-Yanaga, F. & Kahn, M. Targeting Wnt signaling: Can we safely eradicate cancer stem cells?. Clin. Cancer Res. 16, 3153\u20133162. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-09-2943 (2010).","journal-title":"Clin. Cancer Res."},{"key":"13685_CR24","doi-asserted-by":"publisher","first-page":"4085","DOI":"10.21873\/anticanres.11795","volume":"37","author":"S Urushibara","year":"2017","unstructured":"Urushibara, S. et al. WNT\/\u03b2-catenin signaling inhibitor IC-2 suppresses sphere formation and sensitizes colorectal cancer cells to 5-fluorouracil. Anticancer Res. 37, 4085\u20134091. https:\/\/doi.org\/10.21873\/anticanres.11795 (2017).","journal-title":"Anticancer Res."},{"key":"13685_CR25","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1016\/j.bbrc.2012.12.118","volume":"431","author":"Y Ma","year":"2013","unstructured":"Ma, Y. et al. Inhibition of the Wnt-beta-catenin and Notch signaling pathways sensitizes osteosarcoma cells to chemotherapy. Biochem. Biophys. Res. Commun. 431, 274\u2013279. https:\/\/doi.org\/10.1016\/j.bbrc.2012.12.118 (2013).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"13685_CR26","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jbo.2017.09.002","volume":"9","author":"L Xu","year":"2017","unstructured":"Xu, L. et al. Soft tissue recurrence of giant cell tumor of the bone: Prevalence and radiographic features. J. Bone Oncol. 9, 10\u201314. https:\/\/doi.org\/10.1016\/j.jbo.2017.09.002 (2017).","journal-title":"J. Bone Oncol."},{"key":"13685_CR27","doi-asserted-by":"publisher","first-page":"711","DOI":"10.2147\/ott.S117933","volume":"10","author":"CM Yang","year":"2017","unstructured":"Yang, C. M. et al. \u03b2-Catenin promotes cell proliferation, migration, and invasion but induces apoptosis in renal cell carcinoma. Onco. Targets Ther. 10, 711\u2013724. https:\/\/doi.org\/10.2147\/ott.S117933 (2017).","journal-title":"Onco. Targets Ther."},{"key":"13685_CR28","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1038\/s41467-019-09289-5","volume":"10","author":"F Yang","year":"2019","unstructured":"Yang, F. et al. FBXW2 suppresses migration and invasion of lung cancer cells via promoting \u03b2-catenin ubiquitylation and degradation. Nat. Commun. 10, 1382. https:\/\/doi.org\/10.1038\/s41467-019-09289-5 (2019).","journal-title":"Nat. Commun."},{"key":"13685_CR29","doi-asserted-by":"publisher","first-page":"117087","DOI":"10.1016\/j.lfs.2019.117087","volume":"239","author":"TR Shao","year":"2019","unstructured":"Shao, T. R. et al. LncRNA AC007271.3 promotes cell proliferation, invasion, migration and inhibits cell apoptosis of OSCC via the Wnt\/\u03b2-catenin signaling pathway. Life Sci. 239, 117087. https:\/\/doi.org\/10.1016\/j.lfs.2019.117087 (2019).","journal-title":"Life Sci."},{"key":"13685_CR30","doi-asserted-by":"publisher","first-page":"1112","DOI":"10.1053\/j.gastro.2018.11.036","volume":"156","author":"K Peng","year":"2019","unstructured":"Peng, K. et al. Histone demethylase JMJD2D interacts with \u03b2-catenin to induce transcription and activate colorectal cancer cell proliferation and tumor growth in mice. Gastroenterology 156, 1112\u20131126. https:\/\/doi.org\/10.1053\/j.gastro.2018.11.036 (2019).","journal-title":"Gastroenterology"},{"key":"13685_CR31","doi-asserted-by":"publisher","first-page":"561","DOI":"10.7150\/ijbs.19032","volume":"13","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. DNA methylation mediated down-regulation of miR-370 regulates cell growth through activation of the Wnt\/beta-catenin signaling pathway in human osteosarcoma cells. Int. J. Biol. Sci. 13, 561\u2013573. https:\/\/doi.org\/10.7150\/ijbs.19032 (2017).","journal-title":"Int. J. Biol. Sci."},{"key":"13685_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225525","author":"K Maeda","year":"2019","unstructured":"Maeda, K. et al. The regulation of bone metabolism and disorders by Wnt signaling. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms20225525 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"13685_CR33","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/jb\/mvv124","volume":"159","author":"Y Kobayashi","year":"2016","unstructured":"Kobayashi, Y., Uehara, S., Udagawa, N. & Takahashi, N. Regulation of bone metabolism by Wnt signals. J. Biochem. 159, 387\u2013392. https:\/\/doi.org\/10.1093\/jb\/mvv124 (2016).","journal-title":"J. Biochem."},{"key":"13685_CR34","doi-asserted-by":"publisher","first-page":"2405","DOI":"10.1007\/s13277-015-3989-7","volume":"37","author":"A Mirzaei","year":"2016","unstructured":"Mirzaei, A. et al. A new insight into cancer stem cell markers: Could local and circulating cancer stem cell markers correlate in colorectal cancer?. Tumour Biol. 37, 2405\u20132414. https:\/\/doi.org\/10.1007\/s13277-015-3989-7 (2016).","journal-title":"Tumour Biol."},{"key":"13685_CR35","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1007\/s12282-018-0920-2","volume":"26","author":"E Suzuki","year":"2019","unstructured":"Suzuki, E. et al. Gene expression profile of peripheral blood mononuclear cells may contribute to the identification and immunological classification of breast cancer patients. Breast Cancer 26, 282\u2013289. https:\/\/doi.org\/10.1007\/s12282-018-0920-2 (2019).","journal-title":"Breast Cancer"},{"key":"13685_CR36","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/b978-0-12-380866-0.60004-6","volume":"70","author":"M Fabbri","year":"2010","unstructured":"Fabbri, M. & Calin, G. A. Epigenetics and miRNAs in human cancer. Adv. Genet. 70, 87\u201399. https:\/\/doi.org\/10.1016\/b978-0-12-380866-0.60004-6 (2010).","journal-title":"Adv. Genet."},{"key":"13685_CR37","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. J. Int. Bioethique Int. J. Bioethics. 15, 124\u2013129 (2004).","DOI":"10.3917\/jib.151.0124"},{"key":"13685_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbo.2020.100300","volume":"23","author":"A Hosseini","year":"2020","unstructured":"Hosseini, A. et al. The local and circulating SOX9 as a potential biomarker for the diagnosis of primary bone cancer. J. Bone Oncol. 23, 100300. https:\/\/doi.org\/10.1016\/j.jbo.2020.100300 (2020).","journal-title":"J. Bone Oncol."},{"key":"13685_CR39","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.5114\/pjr.2020.98686","volume":"85","author":"S Ahlawat","year":"2020","unstructured":"Ahlawat, S. & Fayad, L. M. Revisiting the WHO classification system of bone tumours: Emphasis on advanced magnetic resonance imaging sequences. Part 2. Polish J. Radiol. 85, e409\u2013e419. https:\/\/doi.org\/10.5114\/pjr.2020.98686 (2020).","journal-title":"Polish J. Radiol."},{"key":"13685_CR40","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1186\/s13052-015-0162-2","volume":"41","author":"M Bozzola","year":"2015","unstructured":"Bozzola, M. et al. Hereditary multiple exostoses and solitary osteochondroma associated with growth hormone deficiency: To treat or not to treat?. Ital. J. Pediatr. 41, 53. https:\/\/doi.org\/10.1186\/s13052-015-0162-2 (2015).","journal-title":"Ital. J. Pediatr."},{"key":"13685_CR41","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/1097-0142(19820315)49:6<1221::aid-cncr2820490625>3.0.co;2-e","volume":"49","author":"G Rosen","year":"1982","unstructured":"Rosen, G. et al. Preoperative chemotherapy for osteogenic sarcoma: Selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy. Cancer 49, 1221\u20131230. https:\/\/doi.org\/10.1002\/1097-0142(19820315)49:6%3c1221::aid-cncr2820490625%3e3.0.co;2-e (1982).","journal-title":"Cancer"},{"key":"13685_CR42","doi-asserted-by":"publisher","first-page":"124","DOI":"10.4103\/jmau.jmau_2_19","volume":"7","author":"S Dhouskar","year":"2019","unstructured":"Dhouskar, S. et al. Comparison of hematoxylin and eosin stain with modified Gallego\u2019s stain for differentiating mineralized components in ossifying fibroma, cemento-ossifying fibroma, and cementifying fibroma. J. Microsc. Ultrastruct. 7, 124\u2013129. https:\/\/doi.org\/10.4103\/jmau.jmau_2_19 (2019).","journal-title":"J. Microsc. Ultrastruct."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13685-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13685-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13685-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T03:55:21Z","timestamp":1669348521000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-13685-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,8]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["13685"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-13685-1","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,8]]},"assertion":[{"value":"15 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 June 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"9488"}}